bpc 157 daily injection dose bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or how much bpc 157 injection
Description
If cloudiness persists or precipitate forms, the peptide may be damaged

It has shown significant weight loss benefits in clinical trials
Digestion : Stomach acids release B12 from food
We firmly believe in the former

Possible side effects may include dizziness, upset stomach, diarrhea, constipation, and loss of appetite
